Cargando…
Racial and Ethnic Diversity in SARS-CoV-2 Vaccine Clinical Trials Conducted in the United States
Evidence shows that White and non-Hispanic individuals are overrepresented in clinical trials. The development of new vaccines and drugs, however, necessitates that clinical research trials include representative participants, particularly in light of evidence showing that underrepresented minoritie...
Autores principales: | Khalil, Lana, Leary, Maranda, Rouphael, Nadine, Ofotokun, Ighovwerha, Rebolledo, Paulina A, Wiley, Zanthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875029/ https://www.ncbi.nlm.nih.gov/pubmed/35214748 http://dx.doi.org/10.3390/vaccines10020290 |
Ejemplares similares
-
A Framework for Inspiring COVID-19 Vaccine Confidence in African American and Latino Communities
por: Wiley, Zanthia, et al.
Publicado: (2022) -
Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV
por: Losada, Cecilia, et al.
Publicado: (2023) -
Racial, Ethnic, and Gender Diversity in United States Ophthalmology Clinical Trials
por: Montazeri, Fateme, et al.
Publicado: (2023) -
Age, Comorbid Conditions, and Racial Disparities in COVID-19 Outcomes
por: Wiley, Zanthia, et al.
Publicado: (2021) -
Sex, racial, and ethnic diversity in clinical trials
por: Bøttern, Julie, et al.
Publicado: (2023)